What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Morie A. Gertz mainly investigates Internal medicine, Multiple myeloma, Surgery, Gastroenterology and Amyloidosis.
Morie A. Gertz has included themes like Immunology and Oncology in his Internal medicine study.
The various areas that Morie A. Gertz examines in his Multiple myeloma study include Dexamethasone and Pathology.
His study in Surgery is interdisciplinary in nature, drawing from both Hematology and Clinical trial.
The Gastroenterology study combines topics in areas such as Creatinine, Progressive disease, Survival analysis and Neutropenia.
The concepts of his Amyloidosis study are interwoven with issues in Nephrotic syndrome, Heart failure, AL amyloidosis and Hematologic Response.
His most cited work include:
- International uniform response criteria for multiple myeloma (2049 citations)
- Improved survival in multiple myeloma and the impact of novel therapies (1718 citations)
- Review of 1027 Patients With Newly Diagnosed Multiple Myeloma (1515 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Surgery, Amyloidosis and Oncology.
Internal medicine and Gastroenterology are frequently intertwined in his study.
His studies deal with areas such as Survival rate and Survival analysis as well as Gastroenterology.
His work focuses on many connections between Multiple myeloma and other disciplines, such as Dexamethasone, that overlap with his field of interest in Cyclophosphamide.
The study incorporates disciplines such as Immunoglobulin light chain, Amyloid, Primary systemic amyloidosis and Immunoglobulin Light-chain Amyloidosis in addition to Amyloidosis.
His Oncology study integrates concerns from other disciplines, such as Waldenstrom macroglobulinemia, Newly diagnosed, Clinical trial and Rituximab.
He most often published in these fields:
- Internal medicine (62.03%)
- Multiple myeloma (46.38%)
- Surgery (27.54%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (62.03%)
- Multiple myeloma (46.38%)
- Amyloidosis (26.43%)
In recent papers he was focusing on the following fields of study:
Morie A. Gertz focuses on Internal medicine, Multiple myeloma, Amyloidosis, Oncology and AL amyloidosis.
As part of his studies on Internal medicine, Morie A. Gertz frequently links adjacent subjects like Gastroenterology.
His research investigates the connection between Gastroenterology and topics such as Cohort that intersect with problems in Hazard ratio.
His Multiple myeloma research is multidisciplinary, incorporating perspectives in Hematopoietic stem cell transplantation, Newly diagnosed, Survival analysis and Bone marrow.
His work carried out in the field of Amyloidosis brings together such families of science as Immunoglobulin light chain, Very Good Partial Response, Transthyretin and Amyloid.
His Oncology research incorporates themes from Waldenstrom macroglobulinemia, Clinical trial, Rituximab and Daratumumab.
Between 2017 and 2021, his most popular works were:
- Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (131 citations)
- Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. (67 citations)
- Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. (47 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary areas of investigation include Internal medicine, Amyloidosis, Multiple myeloma, AL amyloidosis and Gastroenterology.
Many of his studies involve connections with topics such as Oncology and Internal medicine.
He interconnects Immunoglobulin light chain, Transthyretin, Polyneuropathy and Amyloid in the investigation of issues within Amyloidosis.
As part of the same scientific family, he usually focuses on Multiple myeloma, concentrating on Hazard ratio and intersecting with Surgery.
His AL amyloidosis research includes elements of Survival rate, Stem cell, Retrospective cohort study and Very Good Partial Response.
His study on Gastroenterology also encompasses disciplines like
- Bone marrow which is related to area like Myeloma protein,
- Hematopoietic stem cell transplantation that connect with fields like Melphalan.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
